NutritionPD (My Moves Matter)
Mediterranean Diet for Parkinson's — user testing of the programme
Before the MediPD trial, the Mediterranean Diet for Parkinson's programme was tested for three weeks by 30 people with Parkinson's and care partners across the UK, with Parkinson's UK innovation funding, to learn whether it was usable, understandable and acceptable.

What this was
Before a programme is studied in a trial, we test it with the people it is for. In 2025, with innovation funding from Parkinson's UK, NutritionPD ran a three-week user-testing pilot of the Mediterranean Diet for Parkinson's programme with 30 participants across the UK, people with Parkinson's and care partners at different stages and ages. Participants used the video lessons, recipes and meal plans and could ask a dietitian questions in a chat group. Afterwards they were invited to complete an online survey, and ten took part in interviews.
What it was designed to learn
- Engagement and completion — would people start, keep going and finish a short online programme?
- Knowledge and understanding — did the lessons change what people knew about nutrition and Parkinson's?
- Satisfaction and acceptability — was the content clear, trustworthy and pitched at the right level, including the avatar presenter?
- Intentions and self-reported change — did people intend to eat differently, and did any report doing so?
No clinical outcomes were measured. This was user testing, not a clinical study.
What was reported
Participant feedback was positive, and interviewees said the involvement of registered dietitians was central to trusting the information. Several described practical changes, such as eating more vegetables, and a small number reported more regular bowel movements. The team also reported survey results on completion, satisfaction, knowledge and intended behaviour change. We are not publishing those figures here until the survey methods and the number of people answering each question have been confirmed; they will be added, with their denominators, once that review is complete.
Limitations
A small group of 30, a three-week programme, no comparison group, and survey responses from a subset of participants: findings of this kind show whether a programme is usable and acceptable, not whether it improves health. Positive feedback from a self-selected pilot group may not generalise to everyone with Parkinson's.
What happened next
Feedback from the pilot shaped the current version of the programme now on the learner platform, and the programme became the intervention in the MediPD pilot trial with Queen's University Belfast, which is the appropriate place for questions about benefit. Preliminary results of this user testing were presented as a poster at the World Parkinson Congress in May 2026.
Publications and presentations
- "Evaluating the acceptability, engagement, and preliminary efficacy of MediPD: a novel online Mediterranean diet nutrition programme for people with Parkinson's disease (poster P39.29)"
Flanagan R, Reinbacher R · Abstracts of the 7th World Parkinson Congress, Journal of Parkinson's Disease 16(S1), 2026 · 2026 · poster
Facts on this page last reviewed 2026-10-24.
